Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 28, 2019

SELL
$40.6 - $57.2 $60,900 - $85,800
-1,500 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$39.92 - $53.86 $67,864 - $91,562
-1,700 Reduced 53.13%
1,500 $72,000
Q1 2019

Apr 26, 2019

SELL
$48.23 - $66.16 $159,159 - $218,328
-3,300 Reduced 50.77%
3,200 $162,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $305,965 - $402,820
-5,500 Reduced 45.83%
6,500 $385,000
Q3 2018

Oct 29, 2018

SELL
$52.05 - $66.51 $41,640 - $53,208
-800 Reduced 6.25%
12,000 $790,000
Q2 2018

Jul 26, 2018

SELL
$48.33 - $55.64 $53,163 - $61,204
-1,100 Reduced 7.91%
12,800 $646,000
Q4 2017

Feb 13, 2018

SELL
$37.77 - $47.75 $151,080 - $191,000
-4,000 Reduced 22.35%
13,900 $646,000
Q3 2017

Oct 30, 2017

BUY
$34.14 - $40.45 $611,106 - $724,055
17,900
17,900 $724,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $289M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.